Polymorphisms of insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) contribute to pathologic progression in childhood IgA nephropathy

Growth Factors. 2011 Feb;29(1):8-13. doi: 10.3109/08977194.2010.532126. Epub 2010 Nov 4.

Abstract

Previous studies have suggested that insulin-like growth factor-1 (IGF-1) signaling might play an important role in renal fibrosis and regulation of the proliferation of mesangial cells and podocytes. We conducted the present study to investigate association between single nucleotide polymorphisms (SNPs) of IGF-1 (IGF-1) and IGF-1 receptor (IGF-1R) genes and childhood immunoglobulin (Ig) A nephropathy (IgAN). We analyzed five SNPs of IGF-1 and IGF-1R in 188 pediatric IgAN patients and in 263 healthy controls. We compared variations in SNPs in several sets of IgAN subgroups that were designated based on the presence of nephrotic range proteinuria (>40 mg/m2 per h), podocyte foot process effacement, and pathological progression. Genotyping of IgAN patients and controls revealed differences in IGF-1R rs2229765. Moreover, the rs2195239, rs978458, and rs1520220 SNPs of IGF-1 showed significant association with pathological progression. Thus, in the present study, we observed associations between the IGF-1/1R pathway, susceptibility to IgAN, and the pathologic progression of IgAN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Asian People / genetics*
  • Case-Control Studies
  • Child
  • Female
  • Genetic Predisposition to Disease*
  • Glomerulonephritis, IGA / genetics*
  • Glomerulonephritis, IGA / pathology*
  • Humans
  • Insulin-Like Growth Factor I / genetics*
  • Logistic Models
  • Male
  • Polymorphism, Single Nucleotide / genetics*
  • Receptor, IGF Type 1 / genetics*
  • Republic of Korea

Substances

  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1